Pardeep Nijhawan
Chief Executive Officer at Edesa Biotech Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Edesa Biotech Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Edesa Biotech Inc. May 27, 202698.2%
-
Edesa Biotech Inc. May 28, 202597.6%
-
Edesa Biotech Inc. May 23, 202395.1%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 1, 2026 | Edesa Biotech Inc. | Grant or award | +5,714 | — | — |
| Aug 3, 2026 | Edesa Biotech Inc. | Grant or award | +5,324 | — | — |
| Jul 2, 2026 | Edesa Biotech Inc. | Grant or award | +3,378 | — | — |
| Jun 16, 2026 | Edesa Biotech Inc. | Grant or award | +153,550 | $5.21 | $799,996 |
| Jun 1, 2026 | Edesa Biotech Inc. | Grant or award | +1,671 | — | — |
| May 27, 2026 | Edesa Biotech Inc. | Grant or award | +96,913 | — | — |
| May 1, 2026 | Edesa Biotech Inc. | Grant or award | +1,159 | — | — |
| Apr 1, 2026 | Edesa Biotech Inc. | Grant or award | +2,578 | — | — |
| Mar 10, 2026 | Edesa Biotech Inc. | Open-market purchase | +1,000 | $6.60 | $6,600 |
| Mar 5, 2026 | Edesa Biotech Inc. | Open-market purchase | +10,000 | $3.90 | $39,000 |
| Mar 4, 2026 | Edesa Biotech Inc. | Open-market purchase | +10,000 | $4.26 | $42,600 |
| Mar 3, 2026 | Edesa Biotech Inc. | Open-market purchase | +10,000 | $3.63 | $36,300 |
| Mar 2, 2026 | Edesa Biotech Inc. | Open-market purchase | +2,000 | $2.00 | $4,000 |
| Mar 2, 2026 | Edesa Biotech Inc. | Open-market purchase | +1,000 | $2.28 | $2,280 |
| Mar 2, 2026 | Edesa Biotech Inc. | Grant or award | +10,016 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.